SCHEMBL5206672

SCHEMBL5206672

CC(C)N(C=Nc1ncc(Oc2ccc(Cl)cc2)c(=O)[nH]1)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.33
PTGS2 P35354 3/20 0.33
KDM4C Q9H3R0 2/20 0.33
GCK P35557 2/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
CCNC P24863 3/20 0.32
CDK8 P49336 3/20 0.32
LTA4H P09960 1/20 0.32
HTR2A P28223 1/20 0.32
SLC6A4 P31645 1/20 0.32
NPBWR1 P48145 1/20 0.31
MCHR1 Q99705 1/20 0.31
BRD4 O60885 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206665 1.00 PTGS1 (0.33) PTGS1PTGS2KDM4CGCKCYP11B1
SCHEMBL5202933 0.75 L3MBTL1 (0.35) PTGS1PTGS2CCNCCDK8LTA4H
SCHEMBL5202927 0.75 L3MBTL1 (0.35) PTGS1PTGS2CCNCCDK8LTA4H
SCHEMBL7716750 0.71 KDM4C (0.40) PTGS1PTGS2KDM4CCYP11B1CYP11B2
SCHEMBL5202998 0.69 LTA4H (0.57) KDM4CCCNCCDK8LTA4HKDM4E
SCHEMBL5207646 0.69 KDM4C (0.41) PTGS1PTGS2KDM4CCCNCCDK8
SCHEMBL7708436 0.69 LMNA (0.52) PTGS1PTGS2KDM4CCCNCCDK8
SCHEMBL7712513 0.66 HRH4 (0.49) CCNCCDK8ALDH1A1
SCHEMBL5202101 0.65 MERTK (0.34) CCNCCDK8MCHR1
SCHEMBL5202107 0.65 MERTK (0.34) CCNCCDK8MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed